granted
on 08 Jan 2024
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
97240377 filed on 26th Jan 2022
Registration Number
N/A
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceuticaRead More
pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
No 97240377
No Service/Collective Mark
No TM-2168-US-1
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
10th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
08th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
08th Jan 2024 | SOU EXTENSION 3 FILED |
08th Jan 2024 | SOU EXTENSION 3 GRANTED |
20th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
18th Jul 2023 | SOU TEAS EXTENSION RECEIVED |
18th Jul 2023 | SOU EXTENSION 2 FILED |
18th Jul 2023 | SOU EXTENSION 2 GRANTED |
14th Dec 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
12th Dec 2022 | SOU TEAS EXTENSION RECEIVED |